Search alternatives:
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
12 we » 12 wt (Expand Search), 1_ we (Expand Search), 16 we (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
12 we » 12 wt (Expand Search), 1_ we (Expand Search), 16 we (Expand Search)
-
100801
Image_9_CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment.TIF
Published 2021“…Furthermore, the expression of CLEC4H1 (ASGR1) and CLEC4H2 (ASGR2) exhibited a significant relation to clinical stages. However, the expression of CLEC4A, CLEC4D, CLEC4E, CLEC4J (FCER2), CLEC4K (CD207), CLEC4G, CLEC4H1, CLEC4M, and CLEC4H2 decreased with tumor progression. …”
-
100802
The Hepatoselective Glucokinase Activator PF-04991532 Ameliorates Hyperglycemia without Causing Hepatic Steatosis in Diabetic Rats
Published 2014“…During a hyperglycemic clamp in Goto-Kakizaki rats, the glucose infusion rate was increased approximately 5-fold with PF-04991532. …”
-
100803
Image_4_Impact of Computed Tomography-Based, Artificial Intelligence-Driven Volumetric Sarcopenia on Survival Outcomes in Early Cervical Cancer.tif
Published 2021“…During primary treatment, significant decreases in waist skeletal muscle (median, −3.9%; p < 0.001) and total fat (median, −5.3%; p < 0.001) were observed. …”
-
100804
Table_1_3D-Printed PCL/PPy Conductive Scaffolds as Three-Dimensional Porous Nerve Guide Conduits (NGCs) for Peripheral Nerve Injury Repair.DOCX
Published 2019“…PCL/PPy scaffolds with three different concentrations of PPy-b-PCL (0.5, 1, and 2% v/v) were fabricated as a mesh (pore size 125 ± 15 μm) and the effect of incorporation of PPy-b-PCL on mechanical properties, biodegradability, and conductivity of the NGCs were studied. …”
-
100805
Table_6_Impact of Computed Tomography-Based, Artificial Intelligence-Driven Volumetric Sarcopenia on Survival Outcomes in Early Cervical Cancer.docx
Published 2021“…During primary treatment, significant decreases in waist skeletal muscle (median, −3.9%; p < 0.001) and total fat (median, −5.3%; p < 0.001) were observed. …”
-
100806
Image_7_CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment.TIF
Published 2021“…Furthermore, the expression of CLEC4H1 (ASGR1) and CLEC4H2 (ASGR2) exhibited a significant relation to clinical stages. However, the expression of CLEC4A, CLEC4D, CLEC4E, CLEC4J (FCER2), CLEC4K (CD207), CLEC4G, CLEC4H1, CLEC4M, and CLEC4H2 decreased with tumor progression. …”
-
100807
Table_1_Current status, trends, and predictions in the burden of silicosis in 204 countries and territories from 1990 to 2019.DOCX
Published 2023“…The age-period-cohort analysis forecasted a decreasing trend of the burden of silicosis from 2019 to 2044.…”
-
100808
Table_3_Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.xlsx
Published 2023“…Background<p>Lung adenocarcinoma (LUAD) as a frequent type of lung cancer has a 5-year overall survival rate of lower than 20% among patients with advanced lung cancer. …”
-
100809
DataSheet_1_Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.pdf
Published 2023“…Background<p>Lung adenocarcinoma (LUAD) as a frequent type of lung cancer has a 5-year overall survival rate of lower than 20% among patients with advanced lung cancer. …”
-
100810
Table 4_The boundaries between PML and PML-IRIS: difficult to define, pathology may predict.docx
Published 2025“…</p>Results<p>Notably, 63.2% (12/19) of them had blood CD4+ T-cell counts < 200 cells/μl, and 36.8% (7/19) had ≥ 200 cells/μl. 52.9% (9/17) of the patients had elevated CSF protein, 5.3% (1/19) had decreased CSF glucose. Statistical analysis revealed significant correlations between mass effect and both blood CD4+ T-cell counts (P = 0.022) and CSF protein levels (P < 0.001). …”
-
100811
Image 2_MIF tautomerase inhibitor TE-11 prevents inflammatory macrophage activation and glycolytic reprogramming while reducing leukocyte migration and improving Crohn’s disease-li...
Published 2025“…Here, we tested TE-11, a potent MIF tautomerase inhibitor (IC<sub>50</sub> = 5.63 μmol/dm<sup>3</sup>) in experimental Crohn’s disease in male mice, in leukocyte recruitment and in inflammatory M1 macrophage activation.…”
-
100812
Encountering epidemic effects of leaf spot disease (<i>Alternaria brassicae</i>) on <i>Aloe vera</i> by fungal biocontrol agents in agrifields—An ecofriendly approach
Published 2018“…<i>harzianum</i>, standardized at a rate of 2.5 L / plot (36 sq ft) (10<sup>8</sup> spores/ mL) are suggested for the ecofriendly management of this epidemic leaf spot disease of <i>Aloe vera</i> in agricultural fields.…”
-
100813
The Residue-Based Fluctuation Profiles of the Hsp90-Sgt1 and Hsp90-Sgt1-Rar1 Complexes.
Published 2014“…The NMSF profiles for the Hsp90-NTD domains are shown in blue (molecule 1) and red (molecule 2); the NMSF graphs for the Sgt1-CS domain are in green (molecule 3) and cyan (molecule 4); the NMSF plots for the Rar1-CHORD2 domain are in orange (molecule 5) and magenta (molecule 6). The crystal structure residue numbering was converted to a consecutive numbering. …”
-
100814
Validation of the optimum formula.
Published 2025“…The optimized formulation was found to be composed of 19.999, 111.869 and 15 mgs of cholesterol, span 60, and SDC, respectively with a desirability of 0.753. EE%, VS, and ZP were predicted to be 88.4977%, 594.592 nm, and −44.2354 mV, respectively. …”
-
100815
Image 1_MIF tautomerase inhibitor TE-11 prevents inflammatory macrophage activation and glycolytic reprogramming while reducing leukocyte migration and improving Crohn’s disease-li...
Published 2025“…Here, we tested TE-11, a potent MIF tautomerase inhibitor (IC<sub>50</sub> = 5.63 μmol/dm<sup>3</sup>) in experimental Crohn’s disease in male mice, in leukocyte recruitment and in inflammatory M1 macrophage activation.…”
-
100816
Derived from inclusions late in the infectious cycle induce aponecrosis in human aortic endothelial cells-1
Published 2011“…F: HAEC infected for 72 h with 5 IFU/cell. Note that although the cells are infected with different infection doses and fixed at different time points they both elicit the same cell death morphology, thus excluding a cytotoxic effect and underlining the independency of cell death morphology from infection time. …”
-
100817
Quantitative analysis of apoptotic cell death by TUNEL assay.
Published 2016“…Light red dots were not visible in the negative control zebrafish (A). A comparison of the color intensity between the group treated with 125 μM neomycin and the group treated with 500 μM sodium selenite for 1 h showed that the number of TUNEL-positive cells significantly decreased in the 5 and 6-dpf transgenic zebrafish treated with sodium selenite, and that apoptotic cell death of the neuromasts hair cells was attenuated by sodium selenite (green and red-colored fish in the left column, combination of control and TUNEL reaction (a), × 10; red-colored fish in the left middle column, TUNEL reaction (b), × 10; green-colored fish in the right middle column, control for TUNEL reaction (c), × 10; green and red-colored neuromast in the right column, merge for control and TUNEL reaction by high magnification (d), × 40) (A). …”
-
100818
Figure 2 from Auranofin Synergizes with Cisplatin in Reducing Tumor Burden of NOTCH-Dependent Ovarian Cancer
Published 2025“…RBPJ occupancy at <i>HES1</i> and <i>HES4</i> promoters decreased in a dose-dependent manner. <i>CDKN1A</i> (p21) served as a negative control. …”
-
100819
Table_4_CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment.xlsx
Published 2021“…Furthermore, the expression of CLEC4H1 (ASGR1) and CLEC4H2 (ASGR2) exhibited a significant relation to clinical stages. However, the expression of CLEC4A, CLEC4D, CLEC4E, CLEC4J (FCER2), CLEC4K (CD207), CLEC4G, CLEC4H1, CLEC4M, and CLEC4H2 decreased with tumor progression. …”
-
100820
Table_2_Impact of Computed Tomography-Based, Artificial Intelligence-Driven Volumetric Sarcopenia on Survival Outcomes in Early Cervical Cancer.docx
Published 2021“…During primary treatment, significant decreases in waist skeletal muscle (median, −3.9%; p < 0.001) and total fat (median, −5.3%; p < 0.001) were observed. …”